Dr. Paul Michael, MD

Dr. Michael practices at AdventHealth Sebring in Sebring, Florida, part of AdventHealth.

Dr. Michael's NPI, 1477879229, was assigned on April 18, 2010. Dr. Michael graduated from University of Miami, Miller School of Medicine in 2007. Dr. Michael holds Florida license ME124220.

Dr. Michael's primary practice is AdventHealth Sebring, at 4200 Sun N Lake Blvd, Sebring, FL 33872 in Highlands County. The practice phone is (863) 314-4466.

Dr. Michael's primary practice is AdventHealth Sebring in Sebring, Florida, part of AdventHealth. Dr. Michael is also affiliated with BayCare Winter Haven Hospital. The medical group on file is AdventHealth Cancer Institute Sebring. Dmand AI also links Dr. Michael to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Michael practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Michael's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Michael is board certified in interventional cardiology by the National Board of Physicians and Surgeons. Dmand AI has Dr. Michael's licenses on file in 3 states: Florida, Louisiana and Mississippi.

Dmand AI lists leg revascularization among the conditions Dr. Michael treats.

CMS data shows 584 Medicare services from Dr. Michael across 14 procedure codes in 2024, for 216 Medicare patients. Medicare paid $75,977 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 216 Medicare patients who saw Dr. Michael in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Michael's median patient age at 75, with 40% women.

In 2024, Dr. Michael wrote 202 Medicare Part D claims for 87 patients. 89% of them were for generic drugs. CMS names the drug for 117 of them, across 3 drugs with 11 or more claims each, at $9,233 in total drug cost. In 2023, CMS named 432 claims across 13 drugs.

Dr. Michael accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 63 procedures of coronary angioplasty and stenting by Dr. Michael, more than 89% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Michael, published from 2011 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Soil Pollutants, Acer and Microsatellite Repeats. Dr. Michael has published most often in Ecotoxicology. Dr. Michael's most frequent co-authors are Joseph E. Parrillo, MD, Fadi A. Saab, MD and Amjad Almahameed, MD, MPH.

Dmand AI links Dr. Michael to 2 clinical trials. Conditions studied include Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia and Peripheral Vascular Diseases.

CMS Open Payments shows 908 general payments to Dr. Michael from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Boston Scientific Corporation paid the most, $98,498.

Dr. Michael graduated from University of Miami, Miller School of Medicine in 2007. Dr. Michael is a member of ACC and SCAI.

Dr. Michael is in network with 20 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.